|
Market Closed -
Bombay S.E.
06:26:12 2026-09-18 am EDT
|
5-day change | 1st Jan Change | ||
| 120.90 INR | +0.21% |
|
+4.27% | +194.38% |
| Market Cap | 66.25B 690M 602M 568M 516M 967M 971M 6.81B 2.63B 33.68B 2.59B 2.54B 108B | P/E 2025 |
21.8x | P/E 2026 | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 67.79B 706M 616M 582M 528M 990M 994M 6.97B 2.69B 34.46B 2.65B 2.59B 111B | EV / Sales 2025 |
1.45x | EV / Sales 2026 | 1.11x |
| Free-Float |
57.31% | Yield 2025 |
0.42% | Yield 2026 | 0.59% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| MOREPENLAB | Delayed | |
NSE India S.E.
| MOREPENLAB | Delayed |
| 1 day | +0.21% | ||
| 1 week | +4.27% | ||
| Current month | +12.87% | ||
| 1 month | +36.83% | ||
| 3 months | +136.97% | ||
| 6 months | +212.81% | ||
| Current year | +194.38% |
| 1 week | 97 |  | 123.5 |
| 1 month | 88.43 | | 123.5 |
| Current year | 33.44 | | 123.5 |
| 1 year | 33.44 | | 123.5 |
| 3 years | 31.31 | | 123.5 |
| 5 years | 23.65 | | 123.5 |
| 10 years | 7.21 | | 123.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 58 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | +4.27% | +124.05% | +224.22% | 690M | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | |
| Average | +0.20% | +3.36% | +35.94% | +63.19% | 360.24B | |
| Weighted average by Cap. | +0.23% | +3.09% | +35.17% | +61.79% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18.12B 189M 165M 155M 141M 264M 266M 1.86B 719M 9.21B 709M 693M 29.64B | 18.06B 188M 164M 155M 141M 264M 265M 1.86B 716M 9.18B 707M 691M 29.54B |
| Net income | 1.18B 12.3M 10.73M 10.13M 9.2M 17.23M 17.3M 121M 46.81M 600M 46.2M 45.18M 1.93B | 949M 9.89M 8.62M 8.14M 7.39M 13.85M 13.91M 97.52M 37.63M 482M 37.14M 36.32M 1.55B |
| Net Debt | -928K -9.67K -8.43K -7.96K -7.23K -13.55K -13.6K -95.38K -36.81K -472K -36.33K -35.52K -1.52M | 1.54B 16.03M 13.98M 13.2M 11.98M 22.45M 22.55M 158M 61M 782M 60.21M 58.87M 2.52B |
Employees
1,919
Sector
Pharmaceuticals
Calendar
Nov. 13
Earnings release - Q2 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | ₹120.90 | +0.21% | 1,098,795 |
| 26-09-17 | ₹120.65 | +5.28% | 1,322,596 |
| 26-09-16 | ₹114.60 | +7.86% | 2,720,957 |
| 26-09-15 | ₹106.25 | -8.37% | 1,868,528 |
| 26-09-11 | ₹115.95 | +0.69% | 972,729 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
